CoChat
Sign Up
Cited by 742Per- and polyfluoroalkyl substances researchPeroxisome Proliferator-Activated ReceptorsCarcinogens and Genotoxicity Assessment

The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.

The Toxicology of Perfluorooctanoate

Kennedy, Gerald L., Butenhoff, John L., Olsen, Geary W., O'Connor, John C., Seacat, Andrew M., Perkins, Roger G., Biegel, Lisa B., Murphy, Sandra R., Farrar, David G.·2004·Critical Reviews in Toxicology
DOI 10.1080/10408440490464705
Open this paper in CoChat — free account

Abstract

PFOA is a peroxisome proliferator (PPAR agonist) and exerts morphological and biochemical effects characteristic of PPAR agonists. These effects include increased beta-oxidation of fatty acids, increases in several cytochrome P-450 (CYP450)-mediated reactions, and inhibition of the secretion of very low-density lipoproteins and cholesterol from the liver. These effects on lipid metabolism and transport result in a reduction of cholesterol and triglycerides in serum and an accumulation of lipids in the liver. The triad of tumors observed (liver, Leydig cell, and pancreatic acinar-cell) is typical of many PPAR agonists and is believed to involve nongenotoxic mechanisms. The hepatocellular tumors observed in rats are likely to have been the result of the activation of the peroxisome proliferator activated receptor alpha (PPARalpha). The tumors observed in the testis (Leydig-cell) have been hypothesized to be associated with an increased level of serum estradiol in concert with testicular growth factors. The mechanism responsible for the acinar-cell tumors of the pancreas in rats remains the subject of active investigation. The mechanism resulting in the hepatocellular tumors in rats (PPARalpha activation) is not likely to be relevant to humans. Similarly, the proposed mechanism for Leydig-cell tumor formation is of questionable relevance to humans. Acinar tumors of the pancreas are rare in humans, and the relevance of the these tumors, as found in rats, to humans is uncertain. Epidemiological investigations and medical surveillance of occupationally exposed workers have not found consistent associations between PFOA exposure and adverse health effects.

Overview

Integrity signals

Registry

Crossref · 10.1080/10408440490464705

Cites

136 of 136 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 135 references

Research works printed but not linked: 53

  1. Alexander, B.H. (2001). Mortality study of workers employed at the 3M Cottage Grove facility. St. Paul, MN: 3M Company. U.S. EPA Public Docket AR-226-1030a018, Washington, D.C.
  2. Armstrong, F.H., and Lowe, K.C. (1989). Effects of emulsified perfluorochemicals on liver CYP450 in rats. Comp. Biochem. Physiol. 94C:345–349.
  3. Burris, J.M., Lundberg, J.K., Olsen, G., Simpson, C., and Mandel, J. (2002). Interim report No. 2, Determination of serum half-lives of several fluorochemicals. St. Paul (MN), 3M Company. U.S. EPA Public Docket AR-226.
  4. Carney, E.W., Scortichini, B.S., and Crissman, J.W. (1998). Feed restriction during (*) and neonatal life: Effects on reproductive and developmental endpoints in the CD rat. Toxicologist 42:102–103.
  5. Christian, M.S., McCarty, R.J., Cox-Sica, D.K., and Cao, C.P. (1987). Recent increases in the incidences of skull, lung and rib alterations in vehicle control New Zealand white rabbits. J. Am. Coll. Toxicol. 6:562.
  6. Clark, R.L. (1999). Endpoints of reproductive system development. In An evaluation and interpretation of reproductive endpoints for human risk assessment, pp. 27–62. Washington, DC: International Life Sciences Institute, Health and Environmental Science Institute.
  7. Cook, J.C., Hurtt, M.E., Frame, S.R., and Biegel, L.B. (1994). Mechanisms of extrahepatic tumor induction by peroxisome proliferators in Crl:CD R®BR (CD) rats. Toxicologist 14:301.
  8. Davis, J.W. II, Vanden Heuvel, J.P., Kuslikis, B.I., and Peterson, R.E. (1991). Castration increases elimination of perfluorooctanoic acid (PFOA) in male rats. Toxicologist 11:95.
  9. DuPont Company. (1965). Effects of fluorocarbon dispersing agents on the livers of rats and dogs. Haskell Laboratory unpublished report. Newark, DE. Available from GLK on request.
  10. DuPont Company. (1979a). Acute dermal toxicity. Haskell Laboratory unpublished report. Newark, DE.
  11. DuPont Company. (1979b). Eye irritation test in rabbits. Haskell Laboratory unpublished report. Newark, DE.
  12. DuPont Company. (1981a). Ammonium perfluorooctanoate blood levels in the female rat. Haskell Laboratory unpublished report. Newark, DE.
  13. DuPont Company. (1981b). Liver weight comparison in castrated and ovariectomized rats vs. normal rats. Haskell Laboratory unpublished report. Newark, DE.
  14. DuPont Company. (1981c). Oral LD50 test in rats. Haskell Laboratory unpublished report. Newark, DE.
  15. DuPont Company. (1981d). Oral LD50 test in rats. Haskell Laboratory unpublished report. Newark, DE.
  16. DuPont Company. (1981e). Oral LD50 test in mice. Haskell Laboratory unpublished report. Newark, DE.
  17. DuPont Company. (1981f). Oral LD50 test in guinea pigs. Haskell Laboratory unpublished report. Newark, DE.
  18. DuPont Company. (1981g). Mouse feeding study—14 day. Haskell Laboratory unpublished report. Newark, DE.
  19. DuPont Company. (1982a). Excretion and disposition of 14C-ammonium perfluorooctanoate in male and female rats, mice, hamsters, and rabbits. Haskell Laboratory unpublished report. Newark, DE.
  20. DuPont Company. (1982b). Placental transfer of 14C-labelled C-8 in the rat. Haskell Laboratory unpublished report. Newark, DE.
  21. DuPont Company. (1982c). Effect of cholestyramine in the elimination of 14C-ammonium perfluorooctanoate in rats and mice. Haskell Laboratory unpublished report. Newark, DE.
  22. DuPont Company. (1983a). Acute oral toxicity of FC-143 as a function of age. Haskell Laboratory unpublished report. Newark, DE.
  23. DuPont Company. (1983b). APFO liver weights in rats and mice. Oral administration to males and females. Haskell Laboratory unpublished report. Newark, DE.
  24. Gavin, C.E., Martin, N.P., and Schlosser, M.J. (1996). Absence of specific CCK-A binding sites on human pancreatic membranes. Toxicologist 30:334.
  25. Gavin, C.E., Malnoske, J.A., White, J., and Schlosser, M.J. (1997). Species differences in expression of pancreatic cholecystokinin-A receptors. Toxicolo-gist 36:1180.
  26. Gilliland, F.D. (1992). Fluorocarbons and human health: Studies in an occupational cohort. PhD dissertation, University of Minnesota, Minneapolis.
  27. Gortner, E.G. (1981). Oral teratology study of T-2998CoC in rats. Safety Evaluation Laboratory and Riker Laboratories, Inc., Experiment No. 0681TR0110, December 1981. U.S. EPA Public Docket AR-226-0463.
  28. Gortner, E.G. (1982). Oral teratology study of T-3141CoC in rabbits. Safety Evaluation Laboratory and Riker Laboratories, Inc., Experiment No. 0681TB0398, February 1982. U.S. EPA Public Docket AR-226-0465.
  29. Guy, W.S. (1973). Fluorocompounds of human plasma: Analysis, prevalence, purification, and characterization. PhD dissertation, University of Rochester, Rochester, NY.
  30. Hazleton, Inc. (1990). Primary dermal irritation/ corrosion study in rabbits. HLA number 91201740. U.S. EPA Public Docket AR-226-0666, Washington, DC.
  31. Hazleton, Inc. (1995a). Mutagenicity test with T-6342 in the Salmonella–E. coli/mammalian microsome reverse mutation assay. Corning Hazleton, Inc. Final Report CHV Study No. 17073-0-409. December 14, 1995. U.S. EPA Public Docket AR-226-0436, Washington, DC.
  32. Hazleton, Inc. (1995b). Mutagenicity test with T-6342 in an in vivo mouse micronucleus assay. Corning Hazleton, Inc. Final Report CHV Study No. 17073-0-455. December 14, (1995). U.S. EPA Public Docket AR-226-0435, Washington, DC.
  33. Hazleton, Inc. (1995c). Acute dermal toxicity study of T-6342 in rabbits. Corning Hazleton, Inc. HWI 50800374. U.S. EPA Public Docket AR-226-0427, Washington, DC.
  34. Hazleton, Inc. (1996a). Mutagenicity test with T-6564 in the Salmonella-E. coli/mammalian microsome reverse mutation assay with a confirmatory assay. Corning Hazleton, Inc. Final Report CHV Study No. 17750-0-409R. September 13, 1996. U.S. EPA Public Docket AR-226-0432, Washington, DC.
  35. Hazleton, Inc. (1996b). Mutagenicity test with T-6342 measuring chromosomal aberrations in cultured whole blood lymphocytes with a confirmatory assay with multiple harvests. Corning Hazleton, Inc. Final Report CHV Study No. 17073-0-449CO. November 1, 1996. U.S. EPA Public Docket AR-226-0433, Washington, DC.
  36. Hazleton, Inc. (1996c). Mutagenicity test with T-6564 measuring chromosomal aberrations in Chinese hamster ovary (CHO) cells with a confirmatory assay with multiple harvests. Corning Hazleton, Inc. Final Report CHV Study No. 17750-0-437CO. September 16, 1996. U.S. EPA Public Docket AR-226.
  37. Hazleton, Inc. (1996d). Mutagenicity test with T-6342 measuring chromosomal aberrations in Chinese hamster ovary (CHO) cells with a confirmatory assay with multiple harvests. Corning Hazleton, Inc. Final Report CHV Study No. 17073-0-437CO. September 16, 1996. U.S. EPA Public Docket AR-226-0434, Washington, DC.
  38. Hazleton, Inc. (1996e). Mutagenicity test with T-6564 in an in vivo mouse micronucleus assay. Corning Hazleton, Inc. Final Report CHV Study No. 17750-0-455, 1996. U.S. EPA Public Docket AR-226-0430, Washington, DC.
  39. Hazleton, Inc. (1997). Acute oral toxicity study of T-6669 in rats. Corning Hazleton, Inc. CHW 61001760. U.S. EPA Public Docket AR-226-0420, Washington, DC.
  40. Johnson, J.D., and Ober, R.E. (1980). Extent and route of excretion and tissue distribution of total carbon-14 in male and female rats after a single IV dose of FC-143-14C. St. Paul, MN,: Riker Laboratories, Inc. U.S. EPA Public Docket AR-226-0457, Washington, DC.
  41. Kerstner-Wood, C., Coward, L., and Gorman, G. (2003). Protein binding of perfluoroobutane sulfonate, perfluorohexane sulfonate, perfluorooctane sulfonate, and perfluorooctanoate to plasma (human, rat, and monkey), and various human-derived plasma protein fractions. Unpublished report, Southern Research Institute, Study 9921.7. U.S. EPA Public Docket AR-226-1354, Washington, DC.
  42. Litton Bionetics. (1978). Mutagenic evaluation of T-2015 CoC in the Ames Salmonella microsome plate test. Final Report LBI Project No. 20838, February 1978. U.S. EPA Public Docket AR-226-0429, Washington, DC.
  43. Moore, G.E. (2001). H-24921: Dermal sensitization test—Buehler method. Product Safety Labs, Study No. 11321. December 17. Dayton, NJ. Available from GLK on request.
  44. Noker, P. (2003). A pharmacokinetic study of potassium perfluorooctanoate in the cynomologus monkey. Southern Research Institute Study ID: 99214. South Research Institute, submitted to U.S. EPA AR 226-1228, Washington, DC.
  45. Olsen, G.W., Butenhoff, J.L., and Mandel, J.H. (2003c). Assessment of lipid, hepatic and thyroid function in relation to an occupational biologic limit value for perfluorooctanoate. U.S. EPA Public Docket AR-226-1351, Washington, DC.
  46. 10.1345/aph.10228 · DOI · Paper page
  47. Perkins, R.G. (1992). Investigation of ammonium perfluorooctanoate effect on hormone levels and peroxisomal proliferation in the rat. Toxicologist 12:52.
  48. Peterson, R.E., Kuslikis, B.I., and Vanden Heuvel, J.P. (1991). Protein acylation by the peroxisome proliferators perfluorodecanoic acid (PFDA) and perfluorooctanoic acid (PFOA) in rats. Toxicologist 11:185.
  49. Reddy, J.K., and Rao, M.S. (1995). Postulated mechanisms of carcinogenicity mediated by peroxi-some proliferators. IARC Technical Report No. 24, pp. 41–53. Lyon, France.
  50. Riker. (1981). Final Report: Repeat Application 28-Day Percutaneous Absorption Study with T-2618 CoC in Albino Rabbits. Riker Laboratories Report 09790AB0485, March 15, 1981. U.S. EPA Public Docket AR-226-0446, Washington, DC.
  51. Schottenfeld, D. (1996). Testicular cancer. In Cancer epidemiology and prevention, eds. D. Schottenfeld and J.F. Fraumeni, pp. 1207–1219. New York: Oxford University Press.
  52. Stone Research Laboratories. (1981). An assay of cell transformation and cytotoxicity in the C3H 10T 1/2 clonal cell line for the test chemical T-2942 CoC. Environmental Pathology Laboratory, Stone Research Laboratories, University of Minnesota, March 5, 1981. U.S. EPA Public Docket AR-226-0428, Washington, DC.
  53. Toxicon. (2002). CHO/HGPRT Forward mutation assay—ISO Toxicon Final Report: 01-7019-G1. U.S. EPA Public Docket AR-226-1101, Washington, DC.

Cited by

Sorted by citations

Items 301–400 of 741

Related

See all

Metadata

Authors
Kennedy, G. L., Butenhoff, J. L., Olsen, G. W., O'Connor, J. C., Seacat, A. M., Perkins, R. G., Biegel, L. B., Murphy, S. R., & Farrar, D. G.
Affiliations
  • DuPont (United States) (US)
  • 3M (United States) (US)
  • DuPont, Newark, Delaware, USA
  • Covance, Madison, Wisconsin, USA
  • Atofina, Philadelphia, Pennsylvania, USA
  • Ineos (United Kingdom) (GB)
Corresponding author
Kennedy, Gerald L.
ORCID
Venue
Critical Reviews in Toxicology
Publisher
Informa UK Limited
Published
2004-01
Volume
34
Issue
4
Pages
351-384
ISSN
  • 0045-6446 (ISSN-L)
  • 1040-8444
  • 1547-6898
DOI
10.1080/10408440490464705
OpenAlex
W2111493612
Cited by
742
References
135
Citations by year
2026: 8 · 2025: 26 · 2024: 15 · 2023: 25 · 2022: 15 · 2021: 32 · 2020: 30 · 2019: 27 · 2018: 34 · 2017: 32 · 2016: 34 · 2015: 29 · 2014: 42 · 2013: 45 · 2012: 36
FWCI
4.28
Type
journal article
Language
en
Open access
closed
Locations
  • Critical Reviews in Toxicology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
Keywords
perfluorooctanoic acid, PPAR agonists, PPARα, hepatocellular tumors, Leydig cell tumor, lipid metabolism, cytochrome P450, very low density lipoprotein secretion, non-genotoxic carcinogenesis, occupational exposure, toxicokinetics
MeSH terms
Animals, Caprylates, Female, Fluorocarbons, Humans, Leydig Cell Tumor, Liver Neoplasms, Male, Mutagenicity Tests, Pancreatic Neoplasms, Skin, Testicular Neoplasms, Tissue Distribution, Peroxisome Proliferators, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review